Category Archives: Guest Blog

And What Exactly is a Stakeholder?

Pharma’s uncritical use of the word ‘stakeholder’ has increased to the point where it can refer to almost anyone connected to the industry. But this can have serious consequences, warns Reflector. Like it or not (and frankly, I don’t), stakeholders are here to stay in European pharmaceutical affairs. Don’t get me wrong. I’ve no objection to [...]
Also posted in Europe, Global, Regulatory | Tagged , , , , , , , , | 1 Comment

Patients Want to Talk. Do You?

Why are companies rushing to the web when traditional engagement with patient groups remains so under-exploited, asks Jacky Law. It used to be so easy. Patients listened to doctors, doctors listened to pharma and everyone was happy. There was even a time when payers listened to pharma, reimbursing their prices with very few questions asked. Now [...]
Also posted in E-Media, Europe, FDA, Global, Legal | Tagged , , , , , | 1 Comment

HTA Concerns From European Drug Agency

The EMA’s Thomas Lönngren has gone public with his disquiet over organizations such as NICE. But pharma still needs more allies in fighting what it sees as the failings of the health technology assessment bodies, says Pharm Exec Europe’s Brussels correspondent, Reflector. Europe’s pharmaceutical firms were never very keen on Britain’s influential National Institute for Health [...]
Also posted in Europe, Global, Regulatory, Safety, Strategy | Tagged , , , , | Leave a comment

Elmendorf Refuses to Go Quietly Into the Night of HCR

Guest Blog by Tom Norton of NHD Smart Communications. You can reach him at tnorton@nhdcomm.com. Amidst all the gurgling of oil last week(bad! bad! bad!), a competing thunderstorm of words erupted as Doug Elmendorf, Director of CBO, had the temerity to revisit the real costs of the new HCR law. Addressing something that, for whatever reason, [...]
Posted in Guest Blog | Tagged , , , , , , , | 2 Comments

Do You Have a Head of Social Media?

And do you need one? Julian Upton looks at some of the contrasting ideas that emerged from last month’s Digital Pharma Europe event. If anyone had any lingering doubts about an unprecedented era of inclusion and transparency promised by pharma’s newfound, if tentative, embrace of online social media, then last month’s Digital Pharma Europe conference must [...]
Also posted in E-Media, Europe, Events, Strategy, Technology | Tagged , , , , , | 1 Comment